SCHEMBL6818217

SCHEMBL6818217

O=C(NC(c1ccccc1)c1ccccc1)C(Cc1cc(F)cc(F)c1)NS(=O)(=O)Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 3/20 0.41
ITGA2B P08514 2/20 0.41
SLC1A3 P43003 1/20 0.41
SLC1A2 P43004 1/20 0.41
SLC1A1 P43005 1/20 0.41
EEF2K O00418 1/20 0.40
ITGAV P06756 1/20 0.39
KMT2A Q03164 2/20 0.39
F2 P00734 1/20 0.38
MMP9 P14780 3/20 0.38
MMP2 P08253 2/20 0.38
CTSL P07711 1/20 0.38
MMP8 P22894 2/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
MMP1 P03956 1/20 0.38
MMP13 P45452 1/20 0.38
MMP14 P50281 1/20 0.37
ALDH1A1 P00352 2/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6818849 0.87 ITGB3 (0.39) ITGB3ITGA2BSLC1A3SLC1A2SLC1A1
SCHEMBL6818852 0.87 ITGB3 (0.39) ITGB3ITGA2BSLC1A3SLC1A2SLC1A1
Benzene SCHEMBL6818809 0.86 EEF2K (0.42) EEF2KKMT2AMMP9CTSLMMP8
SCHEMBL6813988 0.84 ITGB3 (0.55) ITGB3ITGA2BSLC1A3SLC1A2SLC1A1
SCHEMBL6819764 0.82 MMP2 (0.58) EEF2KMMP9MMP2CTSLMMP8
SCHEMBL6819839 0.80 SLC1A3 (0.45) SLC1A3SLC1A2SLC1A1KMT2AF2
SCHEMBL6819841 0.80 SLC1A3 (0.45) SLC1A3SLC1A2SLC1A1KMT2AF2
SCHEMBL6818927 0.75 CTSL (0.43) SLC1A3SLC1A2SLC1A1MMP9MMP2
SCHEMBL6819150 0.75 CTSL (0.43) SLC1A3SLC1A2SLC1A1MMP9MMP2
SCHEMBL6818664 0.75 HDAC3 (0.45) ITGB3ITGA2BITGAVKMT2AF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004020402-A1 SULPHONYLAMINO DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE DE NOVO PHARMACEUTICALS LIMITED (GB) 2004-03-11 WO claimed
WO-2004020402-A1 SULPHONYLAMINO DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE DE NOVO PHARMACEUTICALS LIMITED (GB) 2004-03-11 WO disclosed